Development of quinolone resistance and prevalence of different virulence genes among Shigella flexneri and Shigella dysenteriae in environmental water samples. (10th January 2020)

• Record Type: Journal Article
• Authors: Roy, B.; Tousif Ahamed, S.K.; Bandyopadhyay, B.; Giri, N.
• Is Part Of: Letters in applied microbiology. Volume 71:Number 1(2020)
• Page Start: 86
• Page End: 93
• Publication Date: 2020-01-10
• Subjects: efflux pump -- environmental surface water -- gyrA mutation -- quinolone resistance -- Shigella; Microbiology -- Periodicals; 660.62
• DOI: 10.1111/lam.13262
• Languages: English
• ISSNs: 0266-8254

Abstract

Abstract: The purpose of this study was to find out the mechanism of quinolone resistance in Shigella sp. isolated from environmental water samples from various parts of Kolkata, India. Out of 196 Shigella sp. isolated from 2014 to 2017, we selected 32 Shigella isolates for antimicrobial susceptibility tests. The minimum inhibitory concentrations (MIC) for quinolones ranged from 30 to 50 μg ml −1 for ofloxacin, 5–20 μg ml −1 for ciprofloxacin and 20–30 μg ml −1 for norfloxacin. A few amino acid changes were found in quinolone resistance determining region (QRDR) of gyrA . Mutations in gyrA lead to a higher increment of MIC of quinolones. Among the plasmid‐mediated (PMQR) quinolone resistance genes investigated, qnrB and aac(6')‐lb‐cr genes were found in all isolates. qnrA and qnrS were found in 25% and 62% of the isolates, respectively. ipaH gene was found in all of the isolates followed by the presence of other virulence genes ial, sen and stx1 . Almost all the isolates having high MICs showed efflux pump activity in drug accumulation assay. All the mechanisms may or may not be present in a single strain. Several types of efflux pumps, presence of PMQR genes and mutations in drug target site of QRDR region may play the crucial role for resistance in our isolates. Abstract : Significance and Impact of the Study: Shigella sp. belonging to the enterobacteriaceae group is the causative agent of shigellosis. Millions die in each year caused by this bloody diarrhoea. Quinolones are used for the treatment of this disease but Shigella is becoming resistant against these drugs. We tried to find out the year wise antibiotic resistance profile, prevalence of virulence genes of Shigella isolates and the possible mechanisms of drug resistance so that an effective strategy to control antibiotic resistance can be designed.